Category: China
-
OxForaâs 14th Intellectual Property and Competition Forum less than one week away (23, 24 June)
The 14th edition of this event will be held in the DPMA Forum, Munich next week. ip fray plans to cover the conference during and after it takes place.
-
Infineon disputes Innoscienceâs claim of âfinal Chinese GaN patent victoryâ
In a statement to ip fray, Infineon said Chinaâs Supreme Peopleâs Court decision concerned preliminary injunction relief and that the main proceedings remain ongoing.
-
Chongqing courtâs higher 5G aggregate royalty burden in ZTE v. Samsung ruling (than in OPPO v. Nokia) has reasons
In ZTE v. Samsung, the Chongqing court explained why the 5G aggregate royalty rate adopted in OPPO v. Nokia should not be treated as an industry-recognised benchmark and characterised it instead as an âinterim figureâ used to resolve a particular dispute.
-
German innovative strength has significantly weakened due to insufficient investment in R&D, report reveals
China has taken ownership of more than 11,300 patents developed in Germany over the past âtwo decades, and that number is likely to keep increasing, according to a study by the âGerman Economic Institute (IW).
-
After the platform peak: Alibabaâs patent map points to the cloud-native AI buildout
Alibabaâs patent map is becoming less about the platform it built first, and more about the infrastructure it is positioning for AI-driven growth, cloud expansion, and the next layer of digital services.
-
Huawei announces new semiconductor law: shows independence from Western chip supply
The new principle, known as âthe Tau (Ď) Scaling Lawâ, has âprovenâ it can resolve global semiconductor and electronic system challenges, and Huawei âwelcomesâ peers in joining it in verifying the law, Huawei announced during the IEEE International Symposium on Circuits and Systems today.
-
China Implements Pharmaceutical Test Data Protection Rules: A New Era for Drug Data Protection
China has promulgated the Measures for the Implementation of Pharmaceutical Test Data Protection and the Work Scheme for Pharmaceutical Test Data Protection, which together operationalize for the first time a formal PTDP system in China, granting up to six years of data exclusivity to qualifying chemical and biological drug applicants.
-
Decoding BYDâs patent footprint: from stack control to scale, from foreign bets to policy friction
BYD used to look, from outside China, like a distant domestic EV champion. It no longer does. This study mines BYDâs patent-family data for the underlying strategy, not just the counts. The result is a map of stack control, foreign bets, and policy-constrained markets.
-
Chinese ZTE v. Samsung FRAND judgment: third way, but much closer to Munich than London; English machine translation and analysis
A redacted version of the full Chinese ZTE v. Samsung FRAND rate judgment has become available over the weekend. Here you can find an English machine translation and a Chinese author’s personal take.
-
Lose three validity battles, win the infringement war? Microsoftâs CNIPA record against Newmanâs GUI patent
A long-running Chinese touchscreen patent dispute between Newman Infinite and Microsoft has now reached China’s Supreme People’s Court, after the latter failed in four patent invalidation attempts. But the record is less one-sided than it currently appears to be.